2m 2m 2m 2m 2m 2m 2m
PROTARA THERAPEU (TARA)
NASDAQ
$2.78+$0.02 (+0.69%)
Price as of Oct 02, 2026 5:49 PM EDT- $163.1MMarket Cap
- -34.60%1-Year Change
- BiotechnologyIndustry
PROTARA THERAPEU (TARA)
$2.78+$0.02 (+0.69%)
TARA | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $2.76 | ||
Change | -$0.29 (-9.51%) | ||
Open | $3.06 | ||
High | $3.10 | ||
Low | $2.75 | ||
Previous Close | $3.05 | ||
Volume | 4,999,036 | ||
30-Day Average Volume | 1,424,662 | ||
1-Week Change | -17.61% | ||
1-Month Change | -29.23% | ||
1-Year Change | -34.60% | ||
3-Year Change | 65.27% | ||
5-Year Change | -60.29% | ||
Fundamentals | |||
Shares Outstanding | 59.1M | ||
Total Assets | $176.1M | ||
Market Cap | $163.1M | ||
Enterprise Value | $146.0M | ||
Period: QTR TTM FY | |||
Revenue | N/A | ||
Net Income | -$17.8M | ||
Free Cash Flow | -$21.3M | ||
EBIT | -$17.8M | ||
EBITDA | -$17.7M | ||
Net Working Capital | $131.1M | ||
EPS | -$0.31 | ||
Enterprise Value/EBITDA | -8 | ||
Enterprise Value/Revenue | N/A | ||
P/B | 1 | ||
P/E | -9 | ||
PEG | -1 | ||
Price/Free Cash Flow | -8 | ||
Price/Operating Cash Flow | -8 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue